Tekla Research Revenue and Competitors

Lake Ridge, VA USA

Location

N/A

Total Funding

Defense

Industry

Estimated Revenue & Valuation

  • Tekla Research's estimated annual revenue is currently $56.2M per year.(i)
  • Tekla Research's estimated revenue per employee is $338,800

Employee Data

  • Tekla Research has 166 Employees.(i)
  • Tekla Research grew their employee count by 16% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.4M38-16%N/AN/A
#2
$207.5M5395%N/AN/A
#3
$63M1863%N/AN/A
#4
$5.2M24-4%N/AN/A
#5
$27.1M88-17%N/AN/A
#6
$42.2M13730%N/AN/A
#7
$8.4M3426%N/AN/A
#8
$3.3M18-10%N/AN/A
#9
$20.2M73-1%N/AN/A
#10
$25.9M84-13%N/AN/A
Add Company

Tekla Research is a company at the forefront of aviation defense technology for over a decade. Founded in 1995, Tekla Research is a Service-Disabled Veteran-Owned Small Business, with a team of talented, experienced, and dedicated individuals offering the highest quality service and dependability. Our employees have an average of 20 years of military/government experience on military avionics integration and testing.

keywords:N/A

N/A

Total Funding

166

Number of Employees

$56.2M

Revenue (est)

16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Tekla Research News

2022-04-17 - Tekla Healthcare Investors (NYSE:HQH) Short Interest Update

Finally, Qube Research & Technologies Ltd acquired a new position in Tekla Healthcare Investors during the fourth quarter worth $597,000.

2022-04-17 - Billionaire Investors Are Buying Healthcare Hand Over Fist

Despite pharma and biotech research being all over the news for two ... Tekla Healthcare Investors (HQH) was established in 1987 and is...

2022-03-30 - Tekla Healthcare Investors: A Dividend Paymaster That Can Compensate For Poor Price Performance

Tekla Healthcare Investors (NYSE:HQH) is a close ended healthcare ... you can enter any ticker and get extensive curated research material.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$71.1M223-8%N/A
#2
$210.9M837N/AN/A
#3
$170.9M12218%N/A
#4
$300M280116%N/A